Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy

Por Zhou, Caicun
Publicado no Transl Lung Cancer Res (2012)

Lung cancer molecular epidemiology in China: recent trends

Por Zhou, Caicun
Publicado no Transl Lung Cancer Res (2014)

Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer

Por Ju Lixia, Zhou Caicun
Publicado em 2013-02-01

Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer

Por Ju, Lixia, Zhou, Caicun
Publicado em 2013

Chemotherapy of lung cancer: A global perspective of the role of ifosfamide

Por Zhou, Caicun, Manegold, Christian
Publicado no Transl Lung Cancer Res (2012)

Preface

Por Pirker, Robert, Zhou, Caicun
Publicado no Transl Lung Cancer Res (2014)

Clinical activity of the mutant-selective EGFR inhibitor AZD9291 in patients with EGFR inhibitor—resistant non-small cell lung cancer

Por Jiang, Tao, Zhou, Caicun
Publicado no Transl Lung Cancer Res (2014)

The past, present and future of immunotherapy against tumor

Por Jiang, Tao, Zhou, Caicun
Publicado no Transl Lung Cancer Res (2015)

Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients

Por Li, Wei, Zhou, Fei, Zhou, Caicun
Publicado em 2014

Something in need is something indeed

Por Zhou, Caicun, Manegold, Christian, Song, Yong
Publicado no Transl Lung Cancer Res (2012)

Role of IL-2 in cancer immunotherapy

Por Jiang, Tao, Zhou, Caicun, Ren, Shengxiang
Publicado no Oncoimmunology (2016)

Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians

Por Wang, Yongsheng, Schmid-Bindert, Gerald, Zhou, Caicun
Publicado em 2012

Chinese expert consensus on molecularly targeted therapy for advanced non-small cell lung cancer (2013 edition)

Por Wu, Guoming, Zhou, Caicun, Bai, Chunxue, Qian, Guisheng
Publicado em 2014

Analyses of prognostic factors in cases of non-small cell lung cancer with multiple brain metastases

Por Gong, Xiaomei, Zhou, Daoan, Liang, Shixiong, Zhou, Caicun
Publicado no Onco Targets Ther (2016)

Transcutaneous electrical acupoint stimulation (TEAS) ameliorates chemotherapy-induced bone marrow suppression in lung cancer patients

Por Hou, Lili, Gu, Fen, Gao, Guanghui, Zhou, Caicun
Publicado no J Thorac Dis (2017)

KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer

Por He, Yayi, Bunn, Paul A., Zhou, Caicun, Chan, Dan
Publicado no Oncotarget (2016)

Once-daily, oral levofloxacin monotherapy for low-risk neutropenic fever in cancer patients: a pilot study in China

Por He, Lixian, Zhou, Caicun, Zhao, Su, Weng, Heng, Yang, Guowang
Publicado no Anticancer Drugs (2015)

The Association between COX-2 Polymorphisms and Hematologic Toxicity in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy

Por Zhou, Fei, Gao, Guanghui, Ren, Shengxiang, Li, Xuefei, He, Yayi, Zhou, Caicun
Publicado em 2013

Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis

Por Jiang, Tao, Wang, Yan, Zhou, Fei, Gao, Guanghui, Ren, Shengxiang, Zhou, Caicun
Publicado no Oncotarget (2015)

Radiotherapy plus EGFR TKIs in non‐small cell lung cancer patients with brain metastases: an update meta‐analysis

Por Jiang, Tao, Min, Weijie, Li, Yanan, Yue, Zhijian, Wu, Chunyan, Zhou, Caicun
Publicado no Cancer Med (2016)